You Are Browsing ‘Health’ Category

GlaxoSmithKline plc (ADR) (NYSE:GSK) and NIH Pushing for an Ebola Vaccine

by Jason Gonzalez - on Aug 29th 2014 - No Comments

Tomahawk, WI 08/29/2014 (Basicsmedia) – Plans to begin Safety trials on an Ebola Vaccine by NIH and GlaxoSmithKline plc (ADR) (NYSE:GSK) are reportedly underway according to CNBC’s Meg Tirrell. Healthy volunteers could be used for the trials as early as next month. The announcement is good news as this is the deadliest Ebola outbreak...

Pfizer Inc. (NYSE:PFE) Unlikely to Be Successful with Second Bid for AstraZeneca plc (ADR) (NYSE:AZN)

by Kevin Thompson - on Aug 26th 2014 - No Comments

Tomahawk, WI 08/26/2014 (Basicsmedia) – AstraZeneca plc (ADR) (NYSE:AZN) shares continue to surge in the market after news emerged that Pfizer Inc. (NYSE:PFE) may table another takeover bid with the three-month ban period that prevented the same under U.K. Laws coming to a close according to CNBC’s correspondent, Catherine Boyle. Pfizer...

Mallinckrodt PLC (NYSE:MNK) Growing at the Back of Major Acquisitions

by Kenneth Hall - on Aug 26th 2014 - No Comments

Tomahawk, WI 08/26/2014 (Basicsmedia) – Mallinckrodt PLC (NYSE:MNK) has maintained a consistent upward trend in the pharmaceutical space according to CNBC’s, Jim Cramer, since going public, as a result of a number of acquisitions that have allowed it to focus on laser-like growth after being spun-off from the parent company, Covidien...

InterMune Inc. (ITMN) Offered a too Good to Refuse Takeover Bid by Roche Holding AG (ROG)

by Kevin Thompson - on Aug 25th 2014 - No Comments

Tomahawk, WI 08/25/2014 (Basicsmedia) – Swiss giant pharmaceutical company Roche Holding AG (ROG) has reportedly tabled an $8.3 billion takeover bid for California-based InterMune Inc. (NASDAQ:ITMN) as one of the ways of expanding its respiratory drugs portfolio according to Deputy Editor EMEA, Surani Fernando, in an interview on CNBC. A...

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Announces Q2 2014 Financial Results, Revenue Increases By $22.5 million

by Paul Rados - on Aug 16th 2014 - No Comments

Tomahawk, WI 08/16/2014 (Basicsmedia) – Merrimack Pharmaceuticals Inc (NASDAQ:MACK) has announced the financial results for the Q2 2014. According to the reports, revenues have increased but it has not been able to generate profit during the second quarter. Details of financial results: Net loss for the quarter as per the reports is...

GlaxoSmithKline plc (ADR) (NYSE:GSK) Interested In Acquiring InterMune Inc. (NASDAQ:ITMN)

by Kenneth Hall - on Aug 14th 2014 - No Comments

Tomahawk, WI 08/14/2014 (Basicsmedia) – Europe’s biggest drug makers led by the likes of Sanofi SA (ADR) (NYSE:SNY) and GlaxoSmithKline plc (ADR) (NYSE:GSK) are said to be in a race against time, to table bids as they push to acquire InterMune Inc. (NASDAQ:ITMN) according to Bloomberg’s Su Keenan. InterMune looks set to be sold’...

Afrezza of MannKind Corporation (NASDAQ:MNKD) To Be Sold By Sanofi

by Cyrus Emen - on Aug 12th 2014 - No Comments

Tomahawk, WI 08/12/2014 (Basicsmedia) – According to recent reports, a French company has paid as much as $925 million to market a drug called Afrezza, that is produced by MannKind Corporation (NASDAQ:MNKD). Afrezza is used in inhaled insulin treatment for people who suffer from diabetes. Details: MannKind Corporation (NASDAQ:MNKD)...

Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), Sarepta Therapeutics Inc. (NASDAQ:SRPT), GlaxoSmithKline plc (ADR) (NYSE:GSK) Surging on Hope of Ebola Prospective Drugs

by Cyrus Emen - on Aug 12th 2014 - No Comments

Tomahawk, WI 08/12/2014 (Basicsmedia) – The ongoing Ebola crisis has been the longest and largest, flipping the script on the disease containment seen by the U.S and Spain flowing some of their infected nationals from West Africa. The contagious disease has aroused a number of ethical issues on the fact that drugs developed by pharmaceutical...

Bristol-Myers Squibb Co (NYSE:BMY), Merck & Co., Inc. (NYSE:MRK) and Genentech Turn Down A patient on Compassionate Drug Usage

by Paul Young - on Aug 11th 2014 - No Comments

Tomahawk, WI 08/11/2014 (Basicsmedia) – Bristol-Myers Squibb Co (NYSE:BMY), Merck & Co., Inc. (NYSE:MRK) and Genentech have developed a drug for a rare form of cancer which Natalie Traller a patient suffering from a rare form of cancer had hoped could be allowed to use on Compassionate basis before final clinical testing. The drug named...

Former GlaxoSmithKline plc (ADR) (NYSE:GSK) Consultants on Trial in China Over Fraud Allegations

by Brian Campbell - on Aug 8th 2014 - No Comments

Tomahawk, WI 08/08/2014 (Basicsmedia) – The trial of an expatriate corporate detective, Peter Humphrey, and Wife Yu Yingzeng, who worked as GlaxoSmithKline plc (ADR) (NYSE:GSK) consultants has officially begun in China according to CNBC’s Eunice Yoon. Humphrey and wife are accused’ of illegally obtaining private information...